TSICM04:	Concomitant Medications Received by =[xx]% of Subjects; Safety Analysis Set (Study jjcs - core)						
 	Active Study Agent 	Active Study Agent 	Active Study Agent 	 	 	
ATC Level 1 	Xanomeline High Dose 	Xanomeline Low Dose 	Combined 	Placebo 	Total 	
  Base Preferred Term 	N=53 	N=73 	N=126 	N=59 	N=185 	
Uncoded 	34 (64.2%) 	35 (47.9%) 	69 (54.8%) 	34 (57.6%) 	103 (55.7%) 	
Uncoded: hydrocortisone, topical 	11 (20.8%) 	12 (16.4%) 	23 (18.3%) 	4 (6.8%) 	27 (14.6%) 	
Uncoded: cortisone 	8 (15.1%) 	4 (5.5%) 	12 (9.5%) 	4 (6.8%) 	16 (8.6%) 	
Uncoded: benadryl 	7 (13.2%) 	6 (8.2%) 	13 (10.3%) 	1 (1.7%) 	14 (7.6%) 	
 	 	 	 	 	 	
Systemic hormonal preparations, excl. 	7 (13.2%) 	9 (12.3%) 	16 (12.7%) 	1 (1.7%) 	17 (9.2%) 	
Hydrocortisone 	7 (13.2%) 	9 (12.3%) 	16 (12.7%) 	1 (1.7%) 	17 (9.2%) 	

Note: Concomitant medications are defined as any therapy used on or after the same day as the first dose of study treatment [up to last dose of study treatment +xx days], including those that started before and continue on after the first dose of study treatment. 	
Note: Concomitant medications are defined as any therapy used on or after the same day as the first dose of study treatment [up to last dose of study treatment +xx days], including those that started before and continue on after the first dose of study treatment.	
Note: Concomitant medications are defined as any therapy used on or after the same day as the first dose of study treatment [up to last dose of study treatment +xx days], including those that started before and continue on after the first dose of study treatment.	
Note: Concomitant medications are defined as any therapy used on or after the same day as the first dose of study treatment [up to last dose of study treatment +xx days], including those that started before and continue on after the first dose of study treatment.	
Note: Concomitant medications are defined as any therapy used on or after the same day as the first dose of study treatment [up to last dose of study treatment +xx days], including those that started before and continue on after the first dose of study treatment.	
Note: Concomitant medications are defined as any therapy used on or after the same day as the first dose of study treatment [up to last dose of study treatment +xx days], including those that started before and continue on after the first dose of study treatment.